The effects of Berberis vulgaris consumption on plasma levels of IGF-1, IGFBPs, PPAR-γ and the expression of angiogenic genes in women with benign breast disease: a randomized controlled clinical trial
The effects of Berberis vulgaris consumption on plasma levels of IGF-1, IGFBPs, PPAR-γ and the expression of angiogenic genes in women with benign breast disease: a randomized controlled clinical trial
نویسندگان: سعید پیروزپناه , علی شایان فر , بهزاد برادران , وحید منتظری , ساناز آسمانی
کلمات کلیدی: Benign breast disease, Berberis vulgaris, Insulin-like growth factor, PPAR, VEGF, HIF
نشریه: 4955 , 19 , 324 , 2019
| نویسنده ثبت کننده مقاله |
سعید پیروزپناه |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات علوم تغذیه |
| کد مقاله |
69922 |
| عنوان فارسی مقاله |
The effects of Berberis vulgaris consumption on plasma levels of IGF-1, IGFBPs, PPAR-γ and the expression of angiogenic genes in women with benign breast disease: a randomized controlled clinical trial |
| عنوان لاتین مقاله |
The effects of Berberis vulgaris consumption on plasma levels of IGF-1, IGFBPs, PPAR-γ and the expression of angiogenic genes in women with benign breast disease: a randomized controlled clinical trial |
| ناشر |
5 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Background: The present study was designed to investigate the effects of Berberis vulgaris (BV) juice consumption
on plasma levels of insulin-like growth factor (IGF-1), IGF-binding proteins (IGFBPs), and the expression of PPAR-γ,
VEGF and HIF in women with benign breast disease.
Methods: This parallel design randomized, double-blind controlled clinical trial was conducted on 85 eligible
patients diagnosed with benign breast disease. They were assigned randomly into either BV juice group (n = 44, BV
juice: 480 ml/day) or placebo group (n = 41, BV placebo juice: 480 ml/day) for 8 weeks intervention. Participants,
caregivers and those who assessed laboratory analyses were blinded to the assignments. Plasma levels of
biomarkers were measured at baseline and after 8 weeks by ELISA. Quantitative real-time PCR was used to measure
the fold change in the expression of each interested gene.
Results: The compliance of participants was 95.2% and 40 available subjects analyzed in each group at last. Relative
treatment (RT) effects for BV juice caused 16% fall in IGF-1 concentration and 37% reduction in the ratio of IGF-1/
1GFBP1. Absolute treatment effect expressed 111 ng/ml increased mean differences of IGFBP-3 between BV group and
placebo. Plasma level of PPAR-γ increased in both groups but it was not significant. Fold changes in the expressions of
PPAR-γ, VEGF and HIF showed down-regulation in the intervention group compared to placebos (P < 0.05).
Conclusions: The BV juice intervention over 8 weeks was accompanied by acceptable efficacy and decreased plasma
IGF-1, and IGF-1/IGFBP-1 ratio partly could be assigned to enhanced IGFBP-1 level in women with BBD. The
intervention caused reductions in the expression levels of PPAR, VEGF, and HIF which are remarkable genomic changes
to potentially prevent breast tumorigenesis.
Trial registration: IRCT2012110511335N2. Registered 10 July 2013 (retrospectively registered) |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| s12906-019-2715-1 (1).pdf | 1398/09/02 | 1593259 | دانلود |